Baxion
Screening
Tags
Alerts
Theme
Perspective Therapeutics, Inc.
CATX
·
AMEX
·
$4.16
Share Price as of 11/2
·
$321M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/10/26
10-Q
Q1 ended 03/31/26
05/11/26
10-K
FY 2025
03/16/26
10-Q
Q3 ended 09/30/25
11/10/25
10-Q
Q2 ended 06/30/25
08/13/25
Disclosures
Filter
8-K
Current report
10/23/26
8-K
Current report
10/08/26
8-K
Other Events
10/01/26
8-K
Current report
09/14/26
8-K
Other Events
09/08/26
Prospectuses and Registrations
Filter
424B5
Prospectus supplement
02/03/26
FWP
Free writing prospectus
02/02/26
POS AM
Post-effective amendment
04/04/25
POS AM
Post-effective amendment
03/26/25
POSASR
Prospectus / registration
03/26/25
Proxies
Filter
DEF 14A
Definitive proxy
04/16/26
DEFA14A
Additional proxy materials
04/16/26
DEF 14A
Definitive proxy
04/16/25
DEFA14A
Additional proxy materials
04/16/25
DEF 14A
Definitive proxy
04/18/24
Ownership
Filter
SC 13D/A
Beneficial ownership (amended)
09/23/26
Form 4
Insider transaction
09/04/26
Form 4
Insider transaction
09/02/26
SC 13G/A
Beneficial ownership (amended)
08/13/26
SC 13G
Beneficial ownership
08/07/26
Other
Filter
SD
Conflict Minerals disclosure
05/19/25
EFFECT
Request for effectiveness
04/08/25
SD
Conflict Minerals disclosure
05/16/24
EFFECT
Request for effectiveness
04/09/24
CORRESP
Correspondence with the SEC
04/08/24
Latest Filings
Filter
8-K
Current report
10/23/26
8-K
Current report
10/08/26
8-K
Other Events
10/01/26
8-K
Current report
09/14/26
8-K
Other Events
09/08/26
Ownership
Filter
SC 13D/A
Beneficial ownership (amended)
09/23/26
Form 4
Insider transaction
09/04/26
Form 4
Insider transaction
09/02/26
SC 13G/A
Beneficial ownership (amended)
08/13/26
SC 13G
Beneficial ownership
08/07/26